iTeos Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Contributed by: GlobeNewswire

Tags

BIOTECHNOLOGY

More Like This

iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates

iTeos Reports Second Quarter 2024 Financial Results and Provides Business Updates

iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates

iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates

iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates

iTeos Announces 2025 Strategic Priorities and Anticipated Milestones

iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

iTeos Reports Topline Interim Results from GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients